Floatz logo

ETOPOSIDE

Bilinear Leukemia

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologySmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

71 Active assets in the Bilinear Leukemia cohort.

Asset / SponsorPhaseRating
Daunorubicin
St. Jude Children's Research Hospital
Phase 4BB
DEXAMETHASONE
St. Jude Children's Research Hospital
Phase 4BB
METHOTREXATE
Children's Oncology Group
Phase 4BB
Cytosin-Arabinosid
Children's Oncology Group
Phase 4BB
Solu-Cortef
Children's Oncology Group
Phase 4BB

View all 50 →

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →